Technical Analysis for RDY - Dr. Reddy's Laboratories Ltd
ADX | Long Term | Intermediate Term | Short Term |
---|---|---|---|
Strong | Up | Flat | Up |
Date | Alert Name | Type | % Chg |
---|---|---|---|
180 Bearish Setup | Bearish Swing Setup | 3.66% | |
Oversold Stochastic | Weakness | 3.66% | |
Slingshot Bearish | Bearish Swing Setup | 2.72% | |
Gapped Up | Strength | 2.72% | |
Oversold Stochastic | Weakness | 2.72% | |
Bullish Engulfing | Bullish | 4.17% | |
Oversold Stochastic | Weakness | 4.17% | |
New Downtrend | Bearish | 4.51% | |
Lower Bollinger Band Touch | Weakness | 4.51% | |
Oversold Stochastic | Weakness | 4.51% |
Alert | Time |
---|---|
50 DMA Resistance | about 1 hour ago |
60 Minute Opening Range Breakout | about 1 hour ago |
Rose Above 50 DMA | about 1 hour ago |
1.5x Volume Pace | about 3 hours ago |
Gapped Up (Full) | about 3 hours ago |
Get a Trading Assistant
- Earnings date: 05/22/2024
Dr. Reddy's Laboratories Ltd Description
Dr. Reddy's Laboratories Limited operates as an integrated pharmaceutical company. It operates in three segments: Pharmaceutical services and Active Ingredients (PSAI), Global Generics, and Proprietary Products. The PSAI segment develops active pharmaceutical ingredients (APIs) and intermediaries, which are used as principal ingredients for finished pharmaceutical products. This segment also offers contract research services to biotech and pharmaceutical companies; and manufactures and sells APIs and steroids in accordance with the specific customer requirements. The Global Generics segment produces and markets finished pharmaceutical products as branded formulations or generic finished dosages. This segment also engages in the operation of biologics business. The Proprietary Products segment engages in the discovery and development of new chemical entities for subsequent commercialization and out-licensing. It offers new, synergistic combination, and technology formulations that modifies pharmacokinetics of existing medicines. This segment is also involved in the Company's specialty pharmaceuticals business that includes sales and marketing operations for in-licensed and co-developed dermatology. The company offers its products and services primarily in the areas of gastrointestinal, cardiovascular, pain management, and oncology therapies. It primarily operates in India, the United States, Russia and other countries of the former Soviet Union, Europe, and others. Dr. Reddy's Laboratories Limited was founded in 1984 and is headquartered in Hyderabad, India.
Classification
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Keywords: Pharmaceutical Pharmaceutical Products Gastrointestinal Dermatology Pain Management Active Pharmaceutical Ingredients Pharmacokinetics Chemical Entities Oncology Therapies Contract Research Services Pharmaceutical Industry In India Pharmaceutical Services Biotech And Pharmaceutical
Indicator | Bull Case | Neutral / Hold | Bear Case |
---|---|---|---|
50 DMA | |||
200 DMA | |||
ADX Trend | |||
Oversold / Overbought | |||
Relative Strength |
Indicator | Value |
---|---|
52 Week High | 77.72 |
52 Week Low | 52.332 |
Average Volume | 177,982 |
200-Day Moving Average | 69.54 |
50-Day Moving Average | 74.23 |
20-Day Moving Average | 72.40 |
10-Day Moving Average | 71.48 |
Average True Range | 0.93 |
RSI (14) | 38.65 |
ADX | 27.16 |
+DI | 16.24 |
-DI | 31.49 |
Chandelier Exit (Long, 3 ATRs) | 71.64 |
Chandelier Exit (Short, 3 ATRs) | 73.51 |
Upper Bollinger Bands | 74.55 |
Lower Bollinger Band | 70.25 |
Percent B (%b) | 0.16 |
BandWidth | 5.94 |
MACD Line | -0.77 |
MACD Signal Line | -0.69 |
MACD Histogram | -0.0733 |
Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
---|---|---|---|---|---|
Resistance 4 (R4) | 72.20 | ||||
Resistance 3 (R3) | 72.29 | 71.96 | 71.98 | ||
Resistance 2 (R2) | 71.96 | 71.64 | 71.91 | 71.91 | |
Resistance 1 (R1) | 71.44 | 71.43 | 71.28 | 71.35 | 71.84 |
Pivot Point | 71.11 | 71.11 | 71.03 | 71.06 | 71.11 |
Support 1 (S1) | 70.59 | 70.79 | 70.43 | 70.50 | 70.00 |
Support 2 (S2) | 70.26 | 70.58 | 70.21 | 69.93 | |
Support 3 (S3) | 69.74 | 70.26 | 69.86 | ||
Support 4 (S4) | 69.65 |